H.R.4392

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Introduced·7/15/25
Introduced

H. R. 4392

Introduced in House · July 24, 2025

July 15, 2025

Ms. Brown (for herself, Ms. Clarke of New York, Ms. Sewell, Mrs. Foushee, Ms. McClellan, Ms. Velázquez, Mr. Fields, Ms. Kelly of Illinois, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia, Ms. Ansari, Mrs. Watson Coleman, Mr. David Scott of Georgia, Mr. Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas, Mrs. McIver, Mr. Carter of Louisiana, Ms. Meng, Ms. Wilson of Florida, Ms. Lee of Pennsylvania, Ms. Simon, Ms. Wasserman Schultz, Mr. Figures, Ms. Adams, Mr. Khanna, Ms. Underwood, Mr. Green of Texas, Ms. Tokuda, Ms. Rivas, Mr. Mannion, Ms. Pressley, Ms. Titus, and Mr. Latimer) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025”.